Product: | Homovanillic acid-d5 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Catalog Number: | D613 | ||||||||||||
CAS Number: | 53587-32-9 | ||||||||||||
Synonyms: | (4-Hydroxy-3-methoxyphenyl-d3)acetic-2,2-d2 Acid | ||||||||||||
Pricing: |
|
||||||||||||
Formula: | C9H5D5O4 | ||||||||||||
Enrichment: | 99%D | ||||||||||||
Molecular Weight: | 187.21 | ||||||||||||
Structure: |
![]() |
||||||||||||
Appearance: | Beige powder | ||||||||||||
Category: | Labeled Reference Standards | ||||||||||||
Stability: | Stable under recommended storage conditions. | ||||||||||||
Storage: |
Keep container tightly closed in a dry and well-ventilated place. Light sensitive. |
||||||||||||
Transportation: |
Non-hazardous for transport |
||||||||||||
Literature References: |
Increased Dopamine D2/D3 Receptor Binding After Recovery from Anorexia Nervosa Measured by Positron Emission Tomography and [11C]Raclopride: ce, cf, c, acg, abc, a, a, c, a, a, h, d, c; Author Affliations: aDepartment of Radiology, Presbyterian University Hospital; bDepartment of Neurology, Presbyterian University Hospital; cDepartment of Psychiatry, Western Psychiatric Institute and Clinic, School of Medicine; dDepartment of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania; eDepartment of Child and Adolescent Psychiatry, School of Medicine, University of California San Diego, San Diego, California; fDepartment of General Psychiatry, University Hospital of Psychiatry, Medical University of Vienna, Vienna, Austria; gNeuroimaging Section, Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland; hGraduate Program in Neuroscience, Department of Neurobiology and Behavior, State University of New York at Stony Brook, Stony Brook, New York. |
||||||||||||
MSDS: | |||||||||||||
Applications: | A labeled metabolite of dihydroxyphenylacetic acid. A neuroendocrine tumor marker. |